New blood pressure monitor could replace needles in autonomic testing

NCT ID NCT05977335

Not yet recruiting Diagnosis Sponsor: CNSystems Medizintechnik GmbH Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a new device that measures blood pressure and heart function continuously without needles. It will be used during standard autonomic function tests (like the Valsalva maneuver and tilt table) in 75 patients with orthostatic intolerance. The goal is to see if the device gives accurate readings compared to current methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Task Force® CORE and Task Force® CARDIO devices
What this could lead to: If successful, this could provide a more comfortable way to monitor blood pressure and heart function during autonomic tests, replacing invasive methods.
What could go wrong: This is an early-stage, small study (75 patients) focused on device accuracy, not treatment. It may not show clear benefits over existing methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTONOMIC DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Orthostatic Intolerance postural orthostatic tachycardia syndrome primary dysautonomia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTONOMIC DYSFUNCTION ORTHOSTATIC INTOLERANCE

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.